Influence of gastritis on cyclooxygenase-2 expression before and after eradication of Helicobacter pylori infection

被引:13
作者
Wambura, C
Aoyama, N
Shirasaka, D
Kuroda, K
Maekawa, S
Ebara, S
Watanabe, Y
Tamura, T
Kasuga, M
机构
[1] Kobe Univ, Dept Endoscopy, Grad Sch Med, Kobe, Hyogo 6500017, Japan
[2] Kobe Univ, Dept Clin Mol Med, Grad Sch Med, Div Diabet Digest & Kidney Dis, Kobe, Hyogo 6500017, Japan
关键词
gastritis; cyclooxygenase-2; expression; Helicobacter pylori eradication;
D O I
10.1097/00042737-200410000-00004
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives Helicobacter pylori infection causes chronic gastritis and induces cyclooxygenase (COX)-2 expression. The relationship between gastritis and COX-2 expression is not well understood, especially long after the organism has been eradicated. We designed a study to elucidate this relationship. Methods Four endoscopic gastric biopsies from each of 118 H. pylori-infected subjects were assessed for COX-2 expression immunohistochemically, gastritis, by an updated Sydney System. In the 107 successfully eradicated subjects, the assessment was repeated once yearly, for 3 years. Results After successful eradication, COX-2 expression was reduced significantly regardless of site. Atrophy improved significantly and intestinal metaplasia improved but not in the antrum greater curvature. After 1 year COX-2 expression was not significantly different in the epithelia with and without intestinal metaplasia. Correlation between COX-2 expression and neutrophil score in the antrum (r= 0.214, P= 0.042) and inflammation in the corpus (r= 0.234, P= 0.025) disappeared after eradication. COX-2 expression correlated well with atrophy and metaplasia before and after eradication. No significant reduction in COX-2 or improvement in gastritis was found in subjects with eradication failure. Conclusion H. pylori infection is associated with the enhancement of COX-2 expression in the gastric mucosa. Eradication therapy reduces COX-2 expression and hence may reduce the risk of cancer development.
引用
收藏
页码:969 / 979
页数:11
相关论文
共 40 条
  • [1] Annibale B, 2000, ALIMENT PHARM THERAP, V14, P625
  • [2] Ciok J, 1997, J Physiol Pharmacol, V48 Suppl 4, P115
  • [3] CORREA P, 1975, LANCET, V2, P58
  • [4] CORREA P, 1990, CANCER-AM CANCER SOC, V66, P2569, DOI 10.1002/1097-0142(19901215)66:12<2569::AID-CNCR2820661220>3.0.CO
  • [5] 2-I
  • [6] Classification and grading of gastritis - The updated Sydney System
    Dixon, MF
    Genta, RM
    Yardley, JH
    Correa, P
    Batts, KP
    Dahms, BB
    Filipe, MI
    Haggitt, RC
    Haot, J
    Hui, PK
    Lechago, J
    Lewin, K
    Offerhaus, JA
    Price, AB
    Riddell, RH
    Sipponen, P
    Solcia, E
    Watanabe, H
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (10) : 1161 - 1181
  • [7] EBHERHAT CE, 1994, GASTROENTEROLOGY, V107, P1183
  • [8] ASSOCIATION BETWEEN INFECTION WITH HELICOBACTER-PYLORI AND RISK OF GASTRIC-CANCER - EVIDENCE FROM A PROSPECTIVE INVESTIGATION
    FORMAN, D
    NEWELL, DG
    FULLERTON, F
    YARNELL, JWG
    STACEY, AR
    WALD, N
    SITAS, F
    [J]. BRITISH MEDICAL JOURNAL, 1991, 302 (6788) : 1302 - 1305
  • [9] Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis
    Fu, SD
    Ramanujam, KS
    Wong, A
    Fantry, GT
    Drachenberg, CB
    James, SP
    Meltzer, SJ
    Wilson, KT
    [J]. GASTROENTEROLOGY, 1999, 116 (06) : 1319 - 1329
  • [10] GENTA RM, 1993, MODERN PATHOL, V6, P281